Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46.2M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
+186K
-
Total reported value, excl. options
-
$124M
-
Value change
-
+$1.4M
-
Number of buys
-
34
-
Number of sells
-
-27
-
Price
-
$8.71
Significant Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q1 2022
87 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q1 2022.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 46.2M outstanding shares and own 30.68% of the company stock.
Largest 10 shareholders include MENORA MIVTACHIM HOLDINGS LTD. (2.95M shares), BlackRock Inc. (1.7M shares), CREDIT SUISSE AG/ (1.09M shares), Harel Insurance Investments & Financial Services Ltd. (1.03M shares), GREAT POINT PARTNERS LLC (873K shares), RTW INVESTMENTS, LP (857K shares), Migdal Insurance & Financial Holdings Ltd. (698K shares), STATE STREET CORP (548K shares), Wildcat Capital Management, LLC (533K shares), and Clal Insurance Enterprises Holdings Ltd (529K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.